Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative Genomic and Functional Approaches Identify FUOM as a Key Driver and Therapeutic Target in Cervical Cancer. | Cancer Rep (Hoboken) | 2025 | 40817807 | PubTator, text mining | PubMed |
| CCR7+ dendritic cells expressing both IL-23A and IL-12B potentially contribute to psoriasis relapse. | Nat Commun | 2025 | 40817122 | PubTator, text mining | PubMed |
| CD70-CAR-Ts: a second wind for high-risk myeloma. | Blood | 2025 | 40811005 | PubTator, text mining | PubMed |
| Comprehensive view on chemotherapy-free management of acute myeloid leukemia by using venetoclax in combination with targeted and/or immune therapies. | Cell Death Discov | 2025 | 40804253 | PubTator, text mining | PubMed |
| CD70-targeted allogeneic CAR T-cell therapy for clear cell renal cell carcinoma. | Expert Rev Anticancer Ther | 2025 | 40803958 | PubTator, text mining | PubMed |
| Anti-CD19 CAR-T cell therapy in relapsed/refractory t(8;21) acute myeloid leukemia with aberrant CD19 expression. | Front Immunol | 2025 | 40761794 | PubTator, text mining | PubMed |
| Identification of novel molecular subtypes and construction of a prognostic signature via multi-omics analysis and machine learning in lung adenocarcinoma. | Front Oncol | 2025 | 40761262 | PubTator, text mining | PubMed |
| Gene expression cluster differences and molecular correlation with the STING pathway in orbital MALT lymphoma and orbital IgG4-related eye disease. | Discov Oncol | 2025 | 40759841 | PubTator, text mining | PubMed |
| Characterization of novel anoikis-related genes as prognostic biomarkers and key determinants of the immune microenvironment in esophageal cancer. | Front Immunol | 2025 | 40746552 | PubTator, text mining | PubMed |
| An integrated approach for analyzing spatially resolved multi-omics datasets from the same tissue section. | Front Mol Biosci | 2025 | 40735471 | PubTator, text mining | PubMed |
| Genetic subtype-guided immunochemotherapy in relapsed and refractory diffuse large B cell lymphoma: a phase 2 investigator-initiated nonrandomized clinical trial (GUIDANCE-06). | Signal Transduct Target Ther | 2025 | 40715072 | PubTator, text mining | PubMed |
| Targets for CAR Therapy in Multiple Myeloma. | Int J Mol Sci | 2025 | 40649828 | PubTator, text mining | PubMed |
| The Role of ENHO in Pancreatic Adenocarcinoma: A Bioinformatics Approach. | Cancers (Basel) | 2025 | 40647442 | PubTator, text mining | PubMed |
| CD70: An emerging target for integrated cancer diagnosis and therapy. | Clin Transl Med | 2025 | 40629902 | PubTator, text mining | PubMed |
| Current Anti-Myeloma Chimeric Antigen Receptor-T Cells: Novel Targets and Methods. | Balkan Med J | 2025 | 40619794 | PubTator, text mining | PubMed |
| Extracellular vesicle impact on immunity following blood transfusion. | Curr Opin Immunol | 2025 | 40609228 | PubTator, text mining | PubMed |
| Novel immunotargets in multiple myeloma: biological relevance and therapeutic potential. | Biomark Res | 2025 | 40597436 | PubTator, text mining | PubMed |
| ADI-270: an armored allogeneic gamma delta T cell therapy designed to target CD70-expressing solid and hematologic malignancies. | J Immunother Cancer | 2025 | 40592738 | PubTator, text mining | PubMed |
| Epitranscriptomics Regulation of CD70, CD80, and TIGIT in Cancer Immunity. | Int J Mol Sci | 2025 | 40565233 | PubTator, text mining | PubMed |
| VSIG4 as a tumor-associated macrophage marker predicting adverse prognosis in diffuse large B-cell lymphoma. | Front Immunol | 2025 | 40539047 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=10